Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16807292 | 0.92 | ALDH1A1 (0.52) | CYP1A2MEN1KMT2AALOX5S1PR3 | |
| SCHEMBL6691326 | 0.92 | KMT2A (0.56) | CYP1A2MEN1KMT2AS1PR3CNR1 | |
| SCHEMBL5559079 | 0.79 | CYP1A2 (0.55) | CYP1A2ALOX5CES2CES1CNR1 | |
| SCHEMBL5778110 | 0.79 | CYP1A2 (0.55) | CYP1A2ALOX5CES2CES1CNR1 | |
| SCHEMBL12280124 | 0.79 | CYP1A2 (0.55) | CYP1A2ALOX5CES2CES1SMN1; SMN2 | |
| SCHEMBL13424144 | 0.78 | ESR1 (0.53) | CYP1A2MEN1KMT2ACNR1CYP2C19 | |
| SCHEMBL29450370 | 0.78 | KMT2A (0.52) | CYP1A2MEN1KMT2AALOX5S1PR3 | |
| SCHEMBL8784244 | 0.77 | CYP1A2 (0.53) | CYP1A2ALOX5CES2CES1CNR1 | |
| SCHEMBL3993015 | 0.77 | CYP1A2 (0.53) | CYP1A2ALOX5CES2CES1CNR1 | |
| SCHEMBL6859146 | 0.77 | CYP1A2 (0.53) | CYP1A2ALOX5CES2CES1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1993992-B1 | TETRAPHENYLNAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | LG CHEMICAL LTD (KR) | 2014-11-26 | — | — | EP | disclosed |
| US-8329316-B2 | Tetraphenylnaphalene derivatives and organic light emitting diode using the same | LG CHEM, LTD. (KR) | 2012-12-11 | — | — | US | disclosed |
| US-20090174312-A1 | Tetraphenylnaphalene Derivatives and Organic Light Emitting Diode Using the Same | LG CHEM, LTD. (KR) | 2009-07-09 | — | — | US | disclosed |
| EP-1993992-A1 | TETRAPHENYLNAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | LG Chem, Ltd. (KR) | 2008-11-26 | — | — | EP | disclosed |
| WO-2007105884-A1 | TETRAPHENYLNAPHTHALENE DERIVATIVES AND ORGANIC LIGHT EMITTING DIODE USING THE SAME | LG CHEM, LTD. (KR) | 2007-09-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090174312-A1 | Tetraphenylnaphalene Derivatives and Organic Light Emitting Diode Using the Same | CRY2, CRY1, PPOX | CYP1A2 2196/4885MEN1 526/4885KMT2A 2050/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.